Clinical Milestones for Novadip Biosciences

Novadip Biosciences announced that the first US patient has been implanted with its investigational tissue regeneration product, NVD-003, in its Phase Ib/IIa clinical trial for Congenital Pseudarthrosis of Tibia (CPT), a rare pediatric bone condition. An autologous therapy derived from a patient’s own adipose stem cells, NVD-003 has the...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us